Shijiazhuang Four Medicine Azithromycin dry suspension suspension in China is approved in China

Great Wall Network · Jiyun Client News (Reporter Yuan Lipeng Correspondent Wu Yuqing) Recently, Azithromycin dried suspension developed by Shijiazhuang Four Pharmaceutical Co., Ltd. obtained the pharmaceutical registration certificate issued by the State Drug Administration, which is regarded as consistent evaluation.The first domestic pharmaceutical company was approved.

Shijiazhuang Four Pharmaceutical Researchers work in the laboratory.Photo by Wu Yuqing

It is reported that Achicillin dried suspension is the second -generation large ring ester antibiotic, which is mainly used for the treatment of bronchitis, pneumonia and other lower respiratory tract infections, skin and soft tissue infections, acute otitis media and sinusitis, pharyngitis, and tonsilYan and other respiratory tract infections.

The clean production workshop of Shijiazhuang Four Medicine.Data picture

The approval of Achicidin's dry suspension will help the diverse development of enterprises, optimize the adjustment of product structure, accelerate the transformation of supply -side structure, and further promote the high -quality development of enterprises.As of now, a total of 27 varieties of Shijiazhuang Four Medicine Group have passed or deemed the consistency evaluation of the quality and efficacy of the national generic drug.

- END -